O

Osteonic Co Ltd
KOSDAQ:226400

Watchlist Manager
Osteonic Co Ltd
KOSDAQ:226400
Watchlist
Price: 6 660 KRW -1.19% Market Closed
Market Cap: 137.6B KRW
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
+1%
Operating Income
Forecast
+26%
Net Income
Forecast
N/A

Wall Street
Price Targets

Price Targets Summary
Osteonic Co Ltd

Wall Street analysts forecast Osteonic Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Osteonic Co Ltd is 9 486 KRW with a low forecast of 9 393 KRW and a high forecast of 9 765 KRW.

Lowest Forecast
Wall Street Target
9 393 KRW
41% Upside
Average Forecast
Wall Street Target
9 486 KRW
42% Upside
Highest Forecast
Wall Street Target
9 765 KRW
47% Upside
Lowest
Price Target
9 393 KRW
41% Upside
Average
Price Target
9 486 KRW
42% Upside
Highest
Price Target
9 765 KRW
47% Upside
Osteonic Co Ltd Competitors:
Price Targets
6849
Nihon Kohden Corp
39% Upside
PRN
Profound Medical Corp
26% Upside
S
SUS
Surgical Science Sweden AB
29% Upside
D
039840
Dio Corp
16% Upside
6849
Nihon Kohden Corp
39% Upside
PRN
Profound Medical Corp
26% Upside
S
SUS
Surgical Science Sweden AB
29% Upside
D
039840
Dio Corp
16% Upside
APYX
Apyx Medical Corp
139% Upside
1789
AK Medical Holdings Ltd
18% Upside
6960
Fukuda Denshi Co Ltd
4% Upside
7575
Japan Lifeline Co Ltd
13% Upside

Revenue
Forecast

Revenue Estimate
Osteonic Co Ltd

For the last 9 years the compound annual growth rate for Osteonic Co Ltd's revenue is 29%. The projected CAGR for the next 2 years is 26%.

29%
Past Growth
26%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Osteonic Co Ltd

For the last 9 years the compound annual growth rate for Osteonic Co Ltd's operating income is 42%. The projected CAGR for the next 2 years is 39%.

42%
Past Growth
39%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Osteonic Co Ltd

For the last 9 years the compound annual growth rate for Osteonic Co Ltd's net income is 32%. The projected CAGR for the next 2 years is 31%.

32%
Past Growth
31%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Osteonic Co Ltd's stock price target?
Price Target
9 486 KRW

According to Wall Street analysts, the average 1-year price target for Osteonic Co Ltd is 9 486 KRW with a low forecast of 9 393 KRW and a high forecast of 9 765 KRW.

What is Osteonic Co Ltd's Revenue forecast?
Projected CAGR
26%

For the last 9 years the compound annual growth rate for Osteonic Co Ltd's revenue is 29%. The projected CAGR for the next 2 years is 26%.

What is Osteonic Co Ltd's Operating Income forecast?
Projected CAGR
39%

For the last 9 years the compound annual growth rate for Osteonic Co Ltd's operating income is 42%. The projected CAGR for the next 2 years is 39%.

What is Osteonic Co Ltd's Net Income forecast?
Projected CAGR
31%

For the last 9 years the compound annual growth rate for Osteonic Co Ltd's net income is 32%. The projected CAGR for the next 2 years is 31%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 262,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.